News
ADC Therapeutics SA (NYSE: ADCT) Q1 2025 Earnings Call Transcript May 14, 2025 ADC Therapeutics SA beats earnings ...
About PYRUKYND® (mitapivat) U.S. INDICATION PYRUKYND is a pyruvate kinase activator indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency.
Michael Colglazier; President, Chief Executive Officer, Director; Virgin Galactic Holdings Inc Douglas Ahrens; Chief Financial Officer, Executive Vice President, Treasurer; Virgin Galactic Holdings ...
The company's move to diversify its product line into into tanks and chambers for water management spured its growth.
The sixth annual virtual Positivity Summit continued with three more presentations designed to help collision business owners ...
3d
Packaging Gateway on MSNDirect-to-consumer packaging: the new face of eCommerceDirect-to-consumer (DTC) packaging is customised packaging used by brands that ship products directly to customers, bypassing ...
Q1 2025 Earnings Call Transcript May 15, 2025 Operator: Hello, and welcome to VEON’s First Quarter 2025 Results Presentation.
During its presentation last year, Netflix announced plans to build its own bespoke ad tech platform to solve advertiser ...
Luminar Technologies, Inc. (NASDAQ: LAZR) Q1 2025 Earnings Call Transcript May 14, 2025 Luminar Technologies, Inc. beats ...
The Marketing Authorization Application (MAA) for Day One Biopharmaceuticals and Ipsen’s tovorafenib was accepted for review ...
Continued advances in AI image creation tools have sparked a bit of a firestorm and backlash, with artists and big tech companies arguing over what’s right and wrong ...
Uber's CEO has faced pushback from employees for rolling back their work-from-home benefits. Here's what he's worth & how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results